Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by besttobeon Mar 04, 2023 8:32pm
113 Views
Post# 35319643

RE:RE:RE:RE:RE:Guidance for Q123 2.5% organic growth! low growth&margins

RE:RE:RE:RE:RE:Guidance for Q123 2.5% organic growth! low growth&marginsThanks for the civil debate ISFCA and the work you put into your rebuttal. Appreciate it.

I don't disagree with your numbers.  However you and I both know the market only sees the 2.5% organic increase. Also even at 25% organic growth the market isn't impressed. Too slow.....and thus why MGT turned to a roll up strategy which is something they said they would not do. 

It is ok to disagree, but I think this will be dead money until they start announcing accretive aquisitions. Probably not until late Q2...We shall see.
<< Previous
Bullboard Posts
Next >>